Development and exacerbation of oral lichen planus during and after interferon therapy for hepatitis C

European Journal of Clinical Investigation

Volumn 26, Issue 12, 1996, Pages 1171-1174

  Nagao, Y ^a   Sata, M ^a   Ide, T ^a   Suzuki, H ^a   Tanikawa, K ^a   Itoh, K ^a   Kameyama, T ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Hepatitis C virus; Interferon; Oral lichen planus

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON;

ARTICLE; CLINICAL ARTICLE; DISEASE COURSE; DRUG EFFECT; DRUG SAFETY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LEUKOPLAKIA; LICHEN PLANUS; MALE; MOUTH DISEASE; PRIORITY JOURNAL;

EID: 0030456178     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1996.610607.x     Document Type: Article

References (24)

1. Johnson RJ, Gretch DR, Yamabe H et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 1993;328:465-70.
2. Hirohata S, Inoue T, Ito K. Development of rheumatoid arthritis after chronic hepatitis caused by hepatitis C virus infection. Intern Med 1992;31:493-5.
3. Misiani R, Bellavita P, Fenili D et al. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med 1992;117:573-7.
4. Pateron D, Hartmann DJ, Duclos-Vallee JC, Jouanolle H, Beaugrand M. Latent autoimmune thyroid disease in patients with chronic HCV hepatitis. J Hepatol 1992;16:244-5.
5. Haddad J, Deny P, Munz-Gotheil C et al. Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 1992;339:321-3.
6. Jubert C, Pawlotsky JM, Pouget F et al. Lichen planus and hepatitis C virus-related chronic active hepatitis. Arch Dermatol 1994;130:73-6.
7. Gandolfo S, Carbone M, Carrozo M, Gallo V. Oral lichen planus and hepatitis C virus (HCV) infection: is there a relationship? A report of 10 cases. J Oral Pathol Med 1994;23:119-22.
8. Nagao Y, Sata M, Tanikawa K, Itoh K, Kameyama T. Lichen planus and hepatitis C virus in the Northern Kyushu region of Japan. Eur J Clin Invest 1995;25:910-4.
9. Pawlotsky JM, Yahia MB, Andre C et al. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 1994;19:841-8.
10. Nagao Y, Sata M, Tanikawa K, Itoh K, Kameyama T. High prevalence of hepatitis C virus antibody and RNA in patients with oral cancer. J Oral Pathol Med 1995;24:354-60.
11. Lau JYN, Davis GL, Kniffen J et al. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993;341:1501-4.
12. Okamoto H, Sugiyama Y, Okada S et al. Typing hepatitis C virus by polymerase chain reaction with type- specific primers: application to clinical surveys and tracing infection sources. J Gen Virol 1992;73:673-9.
13. Andreasen JO. Oral lichen planus. 1. A clinical evaluation of 115 cases. Oral Surg 1968;25:31-42.
14. Nagao Y, Sata M, Fukuizumi K, Harada H, Kameyama T. Oral cancer and hepatitis C virus (HCV): Can HCV alone cause oral cancer? - a case report -. Kurume Med J 1996;43:97-100.
15. Doutre MS, Beylot C, Couzigou P, Long P, Royer P, Beylot J. Lichen planus and virus C hepatitis: disappearance of the lichen under interferon alpha therapy. Dermatol 1992;184:229.
16. Protzer U, Ochsendorf FR, Leopolder-Ochsendorf A, Holtermöller KH. Exacerbation of lichen planus during interferon alpha-2a therapy for chronic active hepatitis C. Gastroenterology 1993;104:903-5.
17. Laskaris G, Sklavounou A, Angelopoulos A. Direct immunofluorescence in oral lichen planus. Oral Surg 1982;53:483-7.
18. Regezi JA, Deegan MJ, Hayward JR. Lichen planus: immunologic and morphologic identification of the submucosal infiltrate. Oral Surg 1978;46:44-52.
19. Dockrell HM, Greenspan JS. Histochemical identification of T cells in oral lichen planus. Oral Surg 1979;48:42-6.
20. Morhenn VB. The etiology of lichen planus. Am J Dermatopathol 1988;8:154-6.
21. Eversole LR. Immunopathology of oral mucosal ulcerative, desquamative, and bullous diseases: selective review of the literature. Oral Surg Oral Pathol Oral Med 1994;77:555-71.
22. Garcia-Buey L, Garcia-Monzon C, Rodriguez S et al. Latent autoimmune hepatitis triggered during interferon therapy in patients with chronic hepatitis C. Gastroenterology 1995;108:1770-7.
23. Yamakawa Y, Sata M, Nakano H et al. Thyroid dysfunction induced by interferon therapy for the treatment of hepatitis type C. A report of 4 cases. Kurume Med J 1995;42:313-19.
24. Nagao Y, Sata M, Itoh K, Tanikawa, Kameyama T. Quantitative analysis of HCV RNA and genotype in patients with chronic hepatitis C accompanied by oral lichen planus. Eur J Clin Invest 1996;26:495-8.